Swiss Stocks Are Lagging Eurozone Peers By the Most Since 1999
Switzerland’s typically staid stock market is headed for its worst annual showing against euro zone peers since 1999,
1970-01-01 08:00
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
1970-01-01 08:00
Novartis Lifts Outlook After Shedding Sandoz Generics
Novartis AG raised its profit forecast for a third time in the drugmaker’s first report after spinning off
1970-01-01 08:00
Roche Taps AI to Find Lung Cancer Patients After Trial Success
Roche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this
1970-01-01 08:00
A Doctor With Brain Cancer Is Helping Transform Its Treatment
When Richard Scolyer was diagnosed with a deadly brain tumor in June, he grasped the test results as
1970-01-01 08:00
Europe Dominates Climate Fund Investing
It turns out the market for environmental-related investment funds is really small in the US, relative to Europe
1970-01-01 08:00
Roche Signs $2.8 Billion Alnylam Deal for Hypertension Drug
Roche Holding AG will work together with Alnylam Pharmaceuticals Inc. on a potential treatment for high blood pressure
1970-01-01 08:00
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
1970-01-01 08:00
US Exposure Is Next Headache for Europe Inc. as Dollar Slides
Behind the facade of Europe’s forecast-beating company earnings, cracks are appearing as exporters start to feel the pinch
1970-01-01 08:00
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
1970-01-01 08:00